It is currently believed that drugs that may cause arrhythmias (such as flecainide and sotalol) should be used with greater caution, and non-dihydropyridine calcium channel blockers should be avoided in patients with HF (201)
We take this step to prevent medication errors which are all too common when dealing with multiple types of units, such as milligrams, milliliters, and international units
The primary hypothesis was that IcoSema is superior to semaglutide 1.0 mg treatment in terms of change in HbA 1c from baseline to week 52
& Bentley, D
Orange Book patent listings and exclusivity records (starting point, not endpoint) USPTO patent prosecution database for continuation applications, patent term adjustments, and terminal disclaimers FDA Written Request publications for pediatric exclusivity signals ANDA filing history, including Paragraph IV certification dates and first-filer identity Federal district court dockets for active Paragraph IV litigation, 30-month stay status, and preliminary ruling signals PTAB docket for active IPR petitions against listed patents IRA negotiation selection lists, which create revenue risk on drugs that survive to their LOE date with Medicare-heavy patient populations International patent registers for key markets, particularly Europe, Japan, and Canada, where competitive entry timelines can signal domestic strategy Beyond patents, calculate all applicable FDA exclusivity windows
